Middletown, DE -- (SBWIRE) -- 09/18/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: A.P. Pharma, Inc.(OTCBB:APPA), Sutor Technology Group Ltd.(NASDAQ:SUTR), BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX), VIVUS, Inc.(NASDAQ:VVUS)
A.P. Pharma, Inc.(OTCBB:APPA) was a volume gainer of 1.41 million shares and the average volume of the stock remained 703,277.00 shares. The stock opened the session at $0.34 and finished at the end of the day at $0.330 and the stock escalated +1.54%.The market capitalization of the stock remained 101.30 million. The half-yearly trend of the stock remained negative -13.16%. A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to release drugs over a defined period of time; and is applicable to a range of therapeutic areas.
For How Long APPA will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Sutor Technology Group Ltd.(NASDAQ:SUTR) exchanged 1.40 million shares and the average volume remained 127,202.00 shares. The stock closed the session at $2.02 with the drop of -11.40%. Tracking three months, the stock was at of +16.09%.
Sutor Technology Group Limited, through its subsidiaries, engages in the manufacture and sale of finished steel products in the People?s Republic of China. The company offers hot-dip galvanized products primarily for use in the electrical household appliance and construction markets; prepainted galvanized products for use in solar energy, appliances.
Why Should Investors Buy SUTR After the Recent Fall? Just Go Here and Find Out
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) decreased -1.23% and its closing price was $6.44. The volume of the stock was 1.38 million shares and the average volume remained 1.73 million shares. Yesterday, the stock traded amid the day price range of $6.39 - $6.93. The market capitalization of the stock remained 375.14 million. The beta of the stock remained 2.98. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop small molecule pharmaceuticals through the structure-guided drug design process.
Will BCRX Get Buyers Even After The Recent Rally? Find Out Here
VIVUS, Inc. (NASDAQ:VVUS) exchanged 1.38 million shares in the previous trading session, and its average trading remained 2.40 million shares. VVUS advanced +0.29% and it closed the trading at $10.36. The market capitalization of the stock remained 1.04 billion. YTD trend of the stock was negative -21.57%. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health. The company offers Qsymia.
For How Long VVUS’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)